It has been about a month since the last earnings report for GSK (GSK) . Shares have added about 10.3% in that time frame, outperforming the S&P 500. Will the recent positive trend continue leading up to its next earnings release, or is Glaxo due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at its most recent earnings report in order to get a better handle on the important catalysts. Beats Q2 Earnings & Sales Estimates, Ups 2024 Guidance GSK ...